Company profile
Immunis, Inc.
Maximizing healthspan and minimizing disease with novel, multi-active therapeutics.
- Industry
- Biotechnology Research
- Employees
- 22
- Headquarters
- Irvine, California
- Founded
- 2019
- LinkedIn followers
- 2,543
- Office locations
- 1
Immunis, Inc. company summary
Immunis, Inc. is a company in the Biotechnology Research industry, headquartered in Irvine, California, founded in 2019. On LinkedIn the company has around 22 employees and 2,543 followers. Its listed specialties include Sarcopenia, Muscle atrophy, Metabolism, Cell therapy, Secretome.
What technology does Immunis, Inc. use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Immunis, Inc.
Immunis Inc. is a private, clinical-stage biotechnology company developing stem cell-derived biologics to address age-related diseases and immune dysfunction. The secretome is the total set of factors secreted by a cell. A well-functioning immune system is necessary for our health and secretomes can refine immune cell responses, making them a promising therapeutic for autoimmune, neurodegenerative and age-related muscle wasting diseases (sarcopenia). Our investigational secretome, IMM01-STEM, includes a balance of all-natural, clinical-grade factors that benefit immune system development, modulation, and health. Immunis’ published pre-clinical data in GeroScience demonstrates that IMM01-STEM benefits muscle regeneration, mass, and function. Immunis published additional data in Aging Cell showing that IMM01-STEM increases whole-body lean mass and reduces fat mass, while increasing muscle size, enhancing muscle regeneration and improving muscle function. 100% of humans develop sarcopenia with age, which significantly impairs mobility and compromises quality of life. Preventing muscle loss and improving muscle recovery are currently unfulfilled medical needs. Immunis' first Phase 1/2a clinical study tested the safety, tolerability, and preliminary efficacy of IMM01-STEM in elderly individuals who have age-related muscle atrophy associated with knee osteoarthritis. Immunis is currently conducting a Phase 2 clinical trial testing IMM01-STEM's safety and efficacy in patients with sarcopenic obesity. Obesity rates have skyrocketed within the past few decades, with a heavy impact on the elderly population. Age-related obesity is strongly linked with additional health concerns including diabetes and muscle loss, which can have detrimental effects on quality of life. “Our innovative therapy shows promising results by simultaneously decreasing fat and enhancing muscle,” explains Chairman Dr. Keirstead.
Specialties
Where is Immunis, Inc. located?
Immunis, Inc. lists 1 location.
Compare companies similar to Immunis, Inc.
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Immunis, Inc. immunisbiomedical.com | Biotechnology Research | 22 | 2019 | Irvine, California |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Immunis, Inc.
What does Immunis, Inc. do?
Immunis Inc. is a private, clinical-stage biotechnology company developing stem cell-derived biologics to address age-related diseases and immune dysfunction. The secretome is the total set of factors secreted by a cell. A well-functioning immune system is necessary for our health and secretomes can refine immune cell responses, making them a promising therapeutic for autoimmune, neurodegenerative and age-related muscle wasting diseases (sarcopenia). Our investigational secretome, IMM01-STEM, includes a balance of all-natural, clinical-grade factors that benefit immune system development, modulation, and health. Immunis’ published pre-clinical data in GeroScience demonstrates that IMM01-STEM benefits muscle regeneration, mass, and function. Immunis published additional data in Aging Cell showing that IMM01-STEM increases whole-body lean mass and reduces fat mass, while increasing muscle size, enhancing muscle regeneration and improving muscle function. 100% of humans develop sarcopenia with age, which significantly impairs mobility and compromises quality of life. Preventing muscle loss and improving muscle recovery are currently unfulfilled medical needs. Immunis' first Phase 1/2a clinical study tested the safety, tolerability, and preliminary efficacy of IMM01-STEM in elderly individuals who have age-related muscle atrophy associated with knee osteoarthritis. Immunis is currently conducting a Phase 2 clinical trial testing IMM01-STEM's safety and efficacy in patients with sarcopenic obesity. Obesity rates have skyrocketed within the past few decades, with a heavy impact on the elderly population. Age-related obesity is strongly linked with additional health concerns including diabetes and muscle loss, which can have detrimental effects on quality of life. “Our innovative therapy shows promising results by simultaneously decreasing fat and enhancing muscle,” explains Chairman Dr. Keirstead.
How many employees does Immunis, Inc. have?
Immunis, Inc. has around 22 employees on LinkedIn.
Where is Immunis, Inc. headquartered?
Immunis, Inc. is headquartered in Irvine, California.
When was Immunis, Inc. founded?
Immunis, Inc. was founded in 2019.
Build a lead list from companies like Immunis, Inc.
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.